Cargando…

A cross-species spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets

Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by the loss of neuronal E3 ligase UBE3A. Restoring UBE3A levels is a potential disease-modifying therapy for AS and has recently entered clinical trials. There is paucity of data regarding the molecular changes downstream of UBE3A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandya, Nikhil J., Meier, Sonja, Tyanova, Stefka, Terrigno, Marco, Wang, Congwei, Punt, A. Mattijs, Mientjes, E. J., Vautheny, Audrey, Distel, Ben, Kremer, Thomas, Elgersma, Ype, Jagasia, Ravi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135630/ https://www.ncbi.nlm.nih.gov/pubmed/35264729 http://dx.doi.org/10.1038/s41380-022-01484-z

Ejemplares similares

Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology
por: Pandya, Nikhil J., et al.
Publicado: (2021)

Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function
por: Avagliano Trezza, Rossella, et al.
Publicado: (2021)

Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations
por: Bossuyt, Stijn N V, et al.
Publicado: (2021)

Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome
por: Sonzogni, Monica, et al.
Publicado: (2020)

The role of ubiquitin ligase E3A in polarized contact guidance and rescue strategies in UBE3A-deficient hippocampal neurons
por: Tonazzini, Ilaria, et al.
Publicado: (2019)

UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
por: Elgersma, Ype, et al.
Publicado: (2021)

A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome
por: Geerts‐Haages, Amber, et al.
Publicado: (2020)

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model
por: Milazzo, Claudia, et al.
Publicado: (2021)

The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome
por: Viho, Eva M. G., et al.
Publicado: (2022)

Conserved UBE3A subcellular distribution between human and mice is facilitated by non-homologous isoforms
por: Zampeta, F Isabella, et al.
Publicado: (2020)

Molecular and behavioral consequences of Ube3a gene overdosage in mice
por: Punt, A. Mattijs, et al.
Publicado: (2022)

Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice
por: Judson, Matthew C., et al.
Publicado: (2021)

A Novel Automated Approach for Improving Standardization of the Marble Burying Test Enables Quantification of Burying Bouts and Activity Characteristics
por: Wahl, Lucas, et al.
Publicado: (2022)

Functional imaging of brain organoids using high-density microelectrode arrays
por: Schröter, Manuel, et al.
Publicado: (2022)

UBE3A expression during early postnatal brain development is required for proper dorsomedial striatal maturation
por: Rotaru, Diana C., et al.
Publicado: (2023)

From first report to clinical trials: a bibliometric overview and visualization of the development of Angelman syndrome research
por: Zampeta, F. Isabella, et al.
Publicado: (2022)

Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes
por: Sonzogni, Monica, et al.
Publicado: (2019)

A brain proteomic investigation of rapamycin effects in the Tsc1(+/−) mouse model
por: Wesseling, Hendrik, et al.
Publicado: (2017)

A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants
por: Sonzogni, Monica, et al.
Publicado: (2018)

Proteomic maps of breast cancer subtypes
por: Tyanova, Stefka, et al.
Publicado: (2016)

Visualization of LC‐MS/MS proteomics data in MaxQuant
por: Tyanova, Stefka, et al.
Publicado: (2015)

SILAC-based quantitative proteomics using mass spectrometry quantifies endoplasmic reticulum stress in whole HeLa cells
por: Itzhak, Daniel N., et al.
Publicado: (2019)

Human Cerebral Organoids Reveal Early Spatiotemporal Dynamics and Pharmacological Responses of UBE3A
por: Sen, Dilara, et al.
Publicado: (2020)

Proteomics reveals the effects of sustained weight loss on the human plasma proteome
por: Geyer, Philipp E, et al.
Publicado: (2016)

Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders
por: Ottenhoff, Myrthe J., et al.
Publicado: (2020)

Crystal Structure of a Ube2S-Ubiquitin Conjugate
por: Lorenz, Sonja, et al.
Publicado: (2016)

α-Calcium Calmodulin Kinase II Modulates the Temporal Structure of Hippocampal Bursting Patterns
por: Cho, Jeiwon, et al.
Publicado: (2012)

Contributions of UBE2C and UBE2S to meiotic progression of porcine oocytes
por: FUJIOKA, Yoshie A., et al.
Publicado: (2018)

A Mass Spectrometry-Based Approach for Mapping Protein Subcellular Localization Reveals the Spatial Proteome of Mouse Primary Neurons
por: Itzhak, Daniel N., et al.
Publicado: (2017)

Phosphorylation Variation during the Cell Cycle Scales with Structural Propensities of Proteins
por: Tyanova, Stefka, et al.
Publicado: (2013)

Global, quantitative and dynamic mapping of protein subcellular localization
por: Itzhak, Daniel N, et al.
Publicado: (2016)

A Mobile PTS2 Receptor for Peroxisomal Protein Import in Pichia pastoris
por: Elgersma, Ype, et al.
Publicado: (1998)

Calmodulin kinase II regulates amphetamine-induced reverse transport in the dopamine transporter: implications for the importance of the dopamine transporter in Angelman syndrome
por: Steinkellner, Thomas, et al.
Publicado: (2010)

The intellectual disability‐associated CAMK2G p.Arg292Pro mutation acts as a pathogenic gain‐of‐function
por: Proietti Onori, Martina, et al.
Publicado: (2018)

Enhanced Transmission at the Calyx of Held Synapse in a Mouse Model for Angelman Syndrome
por: Wang, Tiantian, et al.
Publicado: (2018)

Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans
por: Landers, Miguel, et al.
Publicado: (2005)

UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
por: Guo, Yanjing, et al.
Publicado: (2023)

Genetic interaction screen for severe neurodevelopmental disorders reveals a functional link between Ube3a and Mef2 in Drosophila melanogaster
por: Straub, Jonas, et al.
Publicado: (2020)

In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome
por: Wang, Tiantian, et al.
Publicado: (2015)

Attention and Motor Learning in Adult Patients with Neurofibromatosis Type 1
por: Castricum, Jesminne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bkvgv9bef0k4kf1432nregaea9